Unknown

Dataset Information

0

Discovery of Potent and Selective Inhibitors for ADAMTS-4 through DNA-Encoded Library Technology (ELT).


ABSTRACT: The aggrecan degrading metalloprotease ADAMTS-4 has been identified as a novel therapeutic target for osteoarthritis. Here, we use DNA-encoded Library Technology (ELT) to identify novel ADAMTS-4 inhibitors from a DNA-encoded triazine library by affinity selection. Structure-activity relationship studies based on the selection information led to the identification of potent and highly selective inhibitors. For example, 4-(((4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-6-(((4-methylpiperazin-1-yl)methyl)amino)-1,3,5-triazin-2-yl)amino)methyl)-N-ethyl-N-(m-tolyl)benzamide has IC50 of 10 nM against ADAMTS-4, with >1000-fold selectivity over ADAMT-5, MMP-13, TACE, and ADAMTS-13. These inhibitors have no obvious zinc ligand functionality.

SUBMITTER: Ding Y 

PROVIDER: S-EPMC4538441 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


The aggrecan degrading metalloprotease ADAMTS-4 has been identified as a novel therapeutic target for osteoarthritis. Here, we use DNA-encoded Library Technology (ELT) to identify novel ADAMTS-4 inhibitors from a DNA-encoded triazine library by affinity selection. Structure-activity relationship studies based on the selection information led to the identification of potent and highly selective inhibitors. For example, 4-(((4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-6-(((4-methylpiperazin-  ...[more]

Similar Datasets

| S-EPMC4434457 | biostudies-literature
| S-EPMC9924264 | biostudies-literature
| S-EPMC5150407 | biostudies-literature
| S-EPMC9295786 | biostudies-literature
| S-EPMC6953623 | biostudies-literature
| S-EPMC8201751 | biostudies-literature
| S-EPMC3270411 | biostudies-literature
| S-EPMC4603778 | biostudies-literature
| S-EPMC6912867 | biostudies-literature
| S-EPMC4499826 | biostudies-literature